ScoreWhy is Ishita Drugs & Industries Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 8.40%
- Poor long term growth as Net Sales has grown by an annual rate of 4.99% and Operating profit at 7.71% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.85
2
Flat results in Sep 25
- OPERATING CF(Y) Lowest at Rs -3.64 Cr
- PBDIT(Q) Lowest at Rs 0.19 cr.
- PBT LESS OI(Q) Lowest at Rs 0.15 cr.
3
Below par performance in long term as well as near term
- Along with generating -20.34% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Ishita Drugs for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Ishita Drugs
-20.34%
-0.39
52.45%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.99%
EBIT Growth (5y)
7.71%
EBIT to Interest (avg)
0.85
Debt to EBITDA (avg)
1.49
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
1.44
Tax Ratio
25.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
36.73%
ROE (avg)
8.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
34
Price to Book Value
2.01
EV to EBIT
17.04
EV to EBITDA
15.23
EV to Capital Employed
2.71
EV to Sales
1.00
PEG Ratio
0.72
Dividend Yield
NA
ROCE (Latest)
14.04%
ROE (Latest)
8.99%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET SALES(9M)
At Rs 13.03 cr has Grown at 20.65%
-5What is not working for the Company
OPERATING CF(Y)
Lowest at Rs -3.64 Cr
PBDIT(Q)
Lowest at Rs 0.19 cr.
PBT LESS OI(Q)
Lowest at Rs 0.15 cr.
EPS(Q)
Lowest at Rs 0.47
Loading Valuation Snapshot...
Here's what is working for Ishita Drugs
Net Sales - Latest six months
At Rs 8.47 cr has Grown at 34.44%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Ishita Drugs
Operating Cash Flow - Annually
Lowest at Rs -3.64 Cr
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 0.19 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 0.15 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.47
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
